Management of Chronic Neuropathic Pain With Methadone: A Review of 13 Cases
Abstract
The synthetic opioid methadone has generated much interest in recent years among clinicians involved in the management of intractable chronic cancer pain. Its use as an analgesic is starting to extend to the treatment of noncancer pain, particularly neuropathic pain. Unfortunately, the evidence for its use in the management of neuropathic pain is limited to a few case studies. We examined retrospectively during a 12-month study period the clinical response of all 13 patients at our pain clinic who were prescribed methadone in an attempt to control neuropathic pain resistant to conventional analgesics. A questionnaire was also administered to the 9 patients who continued to take methadone at 12 months posttreatment. A total of 4 patients (31%) discontinued it by the end of the 12-month study period. Patients discontinued methadone due to the absence of pain relief and due to various intractable, undesirable side effects. Somnolence was the most common adverse effect reported, followed by nausea, constipation, and vomiting. All patients took coanalgesics (eg, amitriptyline, gabapentin) or other analgesics (eg, morphine, nonsteroidal anti-inflammatory drugs) during methadone treatment to control pain. The 9 patients who continued to take methadone at 12 months reported experiencing on average 43% pain relief (range 0-80%), 47% improvement in quality of life (range 0-100%), and 30% improvement in quality of sleep (range 0-60%). Methadone was effective at relieving pain and ameliorating quality of life and sleep in 62% of patients. These findings suggest that methadone can offer an acceptable success rate for the treatment of neuropathic pain. Prospective randomized, placebo-controlled studies are now needed to examine more rigorously the benefits of methadone for this type of pain.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Methadone is a long-acting μ-opioid receptor agonist and an NMDA-receptor antagonist with a half-life of 27 ± 12 hours that is effective in treating pain and opioid addiction.
“Methadone is a long-acting μ-opioid receptor agonist and an NMDA-receptor antagonist with a half-life of 27 ± 12 hours that is effective in treating pain and opioid addiction.15–17”
From A Preliminary Study Comparing Methadone and Buprenorphine in Patients with Chronic Pain and Coexistent Opioid Addiction (2013) · cites this paper as [17]
Cites
Farrar, J. T., Young, J. P., LaMoreaux, L., Werth, J. L., & Poole, M. R. (2001) · Pain · doi:10.1016/s0304-3959(01)00349-9 · Cited by 5,808 · see citing works
Clinical Significance of Reported Changes in Pain Severity☆☆☆★
Todd, K. H., Funk, K. G., Funk, J. P., & Bonacci, R. P. (1996) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(96)70238-x · Cited by 1,110 · see citing works
Dickenson, A. H., Chapman, V., & Green, G. M. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)00359-x · Cited by 401 · see citing works
Ripamonti, C. I., Groff, L., Brunelli, C., Polastri, D., Stavrakis, A., & Conno, F. D. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3216 · Cited by 344 · see citing works
Prognostic factors in gastric carcinoma. Results of the German gastric carcinoma study 1992
Roder, J. D., Böttcher, K. A., Siewert, J. R., Busch, R. M., Hermanek, P., Meyer, H., & The German Gastric Carcinoma Study Group (1993) · Cancer · doi:10.1002/1097-0142(19931001)72:7 · Cited by 334 · see citing works
Ebert, B., Andersen, S., & Krogsgaard‐Larsen, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11364-3 · Cited by 255 · see citing works
Davis, M. P., & Walsh, D. (2001) · Supportive Care in Cancer · doi:10.1007/s005200000180 · Cited by 243 · see citing works
Individual variability in the response to different opioids: report of five cases
Galer, B. S., Coyle, N., Pasternak, G. W., et al. (1992) · Pain · doi:10.1016/0304-3959(92)90192-e · Cited by 241 · see citing works
An update on the clinical use of methadone for cancer pain
Ripamonti, C. I., Zecca, E., & Bruera, E. D. (1997) · Pain · doi:10.1016/s0304-3959(96)03286-1 · Cited by 187 · see citing works
Methadone in the management of cancer pain: a review
Fainsinger, R. L., Schoeller, T., & Bruera, E. D. (1993) · Pain · doi:10.1016/0304-3959(93)90125-9 · Cited by 186 · see citing works
What Is Clinically Meaningful: Outcome Measures in Pain Clinical Trials
Farrar, J. T. (2000) · Clinical Journal of Pain · doi:10.1097/00002508-200006001-00018 · Cited by 162 · see citing works
Reassessment of verbal and visual analog ratings in analgesic studies
Littman, G. S., Walker, B. R., & Schneider, B. E. (1985) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1985.127 · Cited by 160 · see citing works
Memories of chronic pain and perceptions of relief
Feine, J. S., Lavigne, G. J., Dao, T. T. T., Morin, C., & Lund, J. P. (1998) · Pain · doi:10.1016/s0304-3959(98)00089-x · Cited by 155 · see citing works
Ozaki, T., Hillmann, A., Hoffmann, C., Rübe, C., Blasius, S., Dunst, J., Jürgens, H., & Winkelmann, W. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960815)78:4 · Cited by 138 · see citing works
NMDA-Receptor Antagonists in Neuropathic Pain
Sang, C. N.-M. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(99)00125-6 · Cited by 136 · see citing works
Strategies for the Treatment of Cancer Pain in the New Millennium
Ripamonti, C. I., & Dickerson, E. D. (2001) · Drugs · doi:10.2165/00003495-200161070-00005 · Cited by 136 · see citing works
Conno, F. D., Groff, L., Brunelli, C., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2836 · Cited by 118 · see citing works
The rediscovery of methadone for cancer pain management
Ayonrinde, O. T., & Bridge, D. T. (2000) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2000.tb139323.x · Cited by 95 · see citing works
Gagnon, B., & Bruera, E. D. (1999) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(99)00049-4 · Cited by 89 · see citing works
Hagen, N. A., & Wasylenko, E. (1999) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(99)00083-4 · Cited by 68 · see citing works
Patient-controlled analgesia with oral methadone in cancer pain: Preliminary report
Mercadante, S., Sapio, M., Serretta, R., & Caligara, M. (1996) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a010679 · Cited by 68 · see citing works
Methadone in cancer pain management: individualize dose and titrate to effect.
Foley, K. M., & Houde, R. W. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3213 · Cited by 49 · see citing works
Altier, N., Dion, D., Boulanger, A., & Choinière, M. (2001) · Burns · doi:10.1016/s0305-4179(01)00032-8 · Cited by 46 · see citing works
Self-citationOral methadone for managing chronic nonmalignant pain
Gardner‐Nix, J. (1996) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(95)00191-3 · Cited by 40 · see citing works
Ivarsson, M., & Neil, A. (1989) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1989.tb01190.x · Cited by 37 · see citing works
Morphine- and methadone-tolerant mice differ in cross-tolerance to other opiates
Neil, A. (1982) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00499071 · Cited by 34 · see citing works
Pseudoglandular hepatocellular carcinoma. A morphogenetic study
Kondō, Y., & Nakajima, T. (1987) · Cancer · doi:10.1002/1097-0142(19870901)60:5 · Cited by 33 · see citing works
Use of Methadone in Treating Chronic Noncancer Pain
Hays, H., & Woodroffe, M. A. (1999) · Pain Research and Management · doi:10.1155/1999/343209 · Cited by 21 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Neumann, A. M., Blondell, R. D., Jaanimägi, U., Giambrone, A. K., Homish, G. G., Lozano, J. R., Kowalik, U., & Azadfard, M. (2013) · Journal of Addictive Diseases · doi:10.1080/10550887.2012.759872 · Cited by 90 · see citing works
Blondell, R. D., Ashrafioun, L., Dambra, C. M., Foschio, E. M., Zielinski, A. L., & Salcedo, D. M. (2010) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e3181ba895d · Cited by 59 · see citing works
- Authors
- Altier, N., Dion, D., Boulanger, A., & Choinière, M.
- Affiliations
- Centre Hospitalier de l’Université de Montréal (CA)
- Corresponding author
- Altier, Nadège
- Dion, Dominique
- Choinière, Manon
- ORCID
- Choinière, Manon
- Venue
- The Clinical Journal of Pain
- Published
- 2005-07
- Volume
- 21
- Issue
- 4
- Pages
- 364-369
- ISSN
- 0749-8047 (ISSN-L)
- OpenAlex
- W2008337251
- Cited by
- 40
- References
- 28
- Citations by year
- 2025: 2 · 2024: 1 · 2019: 3 · 2018: 1 · 2017: 4 · 2015: 3 · 2014: 3 · 2013: 4 · 2012: 4
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Journal of Pain (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Surgery › Anesthesia and Pain Management
- Keywords
- methadone, neuropathic pain, chronic pain management, synthetic opioids, non-cancer pain, analgesia, quality of life, sleep quality, adverse effects, sleepiness, gabapentin, amitriptyline, treatment discontinuation
- MeSH terms
- Adult, Aged, Analgesics, Opioid, Chronic Disease, Drug Administration Schedule, Drug Therapy, Combination, Female, Humans, Male, Methadone, Middle Aged, Neuralgia, Pain Measurement, Quality of Life, Surveys and Questionnaires, Retrospective Studies, Sleep Wake Disorders, Receptors, N-Methyl-D-Aspartate, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review